YAP1acts as oncogenic target of 11q22 amplification in multiple cancer subtypes
Open Access
- 23 March 2014
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 5 (9) , 2608-2621
Abstract
The transcriptional coactivator YAP1 is a critical effector of the human Salvador-Warts-Hippo pathway. Literature data report apparently discrepant results on the carcinogenic role of YAP1, which acts either as oncogene or as tumor suppressor in different in vitro and in vivo models. Furthermore, genomic amplification events of 11q22 locus encompassing YAP1 gene have been detected in multiple tumor types but there is limited direct evidence about the oncogenic role of endogenous YAP1 within in the amplicon.Keywords
This publication has 57 references indexed in Scilit:
- The Hippo Signaling Pathway in Development and CancerDevelopmental Cell, 2010
- YAP1 and VGLL3, encoding two cofactors of TEAD transcription factors, are amplified and overexpressed in a subset of soft tissue sarcomasGenes, Chromosomes and Cancer, 2010
- Structural and functional analysis of the YAP-binding domain of human TEAD2Proceedings of the National Academy of Sciences, 2010
- YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferationGenes & Development, 2009
- Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth controlGenes & Development, 2007
- RASSF1A Elicits Apoptosis through an MST2 Pathway Directing Proapoptotic Transcription by the p73 Tumor Suppressor ProteinMolecular Cell, 2007
- Elucidation of a Universal Size-Control Mechanism in Drosophila and MammalsCell, 2007
- Matrix metalloproteinases and the regulation of tissue remodellingNature Reviews Molecular Cell Biology, 2007
- Transforming properties of YAP , a candidate oncogene on the chromosome 11q22 ampliconProceedings of the National Academy of Sciences, 2006
- Identification and Validation of Oncogenes in Liver Cancer Using an Integrative Oncogenomic ApproachCell, 2006